Vertex Pharmaceuticals, Inc. (VRTX)

S&amp;P 500: 1,262.90
Change: 0.11%

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

Recs

Avatar genedom (97.60) Submitted: 9/27/07 2:45 AM : Start Price: $37.99 VRTX Score: -6.81

A 5-billion dollar company with the drug approval two years away is too pricey for me. Not mention anything can happen in phase III trial.

Featured Broker Partners